COMPANIES COVERED
3M CompanyDownload FREE Report Sample
Download Free sampleDendritic cells (DCs) refer to rare kind of leukocytes. They have prompted their recent application to therapeutic cancer vaccinations as they are uniquely effective in their ability to present antigens to T cells. Isolated DCs loaded with tumor antigen ex vivo and administered as a cellular vaccine are found to induce protective and therapeutic anti-tumor immunity in experimental animals.
Dendritic Cell Cancer Vaccines Market contains market size and forecasts of Dendritic Cell Cancer Vaccines in Global, including the following market information:
Global Dendritic Cell Cancer Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Dendritic Cell Cancer Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
CreaVax Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dendritic Cell Cancer Vaccines include 3M Company, Activarti, Argos Therapeutics, Batavia Bioservices, Bellicum Pharmaceuticals, Creagene, DanDrit Biotech, DCPrime and Sanpower Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Dendritic Cell Cancer Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dendritic Cell Cancer Vaccines Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Dendritic Cell Cancer Vaccines Market Segment Percentages, by Type, 2021 (%)
CreaVax
Sipuleucel-T (Provenge)
Others
Global Dendritic Cell Cancer Vaccines Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Dendritic Cell Cancer Vaccines Market Segment Percentages, by Application, 2021 (%)
Pediatrics
Adults
Global Dendritic Cell Cancer Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Dendritic Cell Cancer Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dendritic Cell Cancer Vaccines revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Dendritic Cell Cancer Vaccines revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
3M Company
Activarti
Argos Therapeutics
Batavia Bioservices
Bellicum Pharmaceuticals
Creagene
DanDrit Biotech
DCPrime
Sanpower Corporation
Elios Therapeutics
ImmunoCellular Therapeutics
Immunicum
Kiromic
Medigene
Merck
Northwest Biotherapeutics
Glaxo Smith Kline
Tellaorporation
Vaxil BioTherapeutics
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
